Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021
Net Income	-37.47	-38.72	12.01	-99.56	-116.72	-32.29
Depreciation & Amortization	8.34	8.03	7.95	13.18	18.06	19.87
Stock-Based Compensation	9.44	10.16	6.2	3.61	2.61	3.36
Other Adjustments	47.43	25.02	-22.21	45.54	76.55	15.78
Change in Receivables	2.2	-2.26	-3.26	10.82	-6.14	5.78
Changes in Inventories	10.28	7.69	0.86	-14.81	-2.18	-2.82
Changes in Accounts Payable	-3.87	-1.67	-6.68	16.04	9.34	-5.98
Changes in Accrued Expenses	-7.21	-5.92	1.65	-0.49	-3.42	4.08
Changes in Unearned Revenue	-	-	-	6.08	-0.02	0.43
Changes in Other Operating Activities	-2.27	-2.53	3.73	2.16	-0.69	8.28
Operating Cash Flow	5.14	-0.21	0.26	-17.44	-22.59	16.47
Operating Cash Flow Growth	60.90%	-	-	-	-	-
Capital Expenditures	-11.11	-13.42	-18.4	-21.48	-29.94	-25.22
Sale of Property, Plant & Equipment	3.5	7	-	-	1.14	12.91
Proceeds from Sale of Investments	-	-	-	-	45.1	-
Proceeds from Business Divestments	-	-	-	16.67	63.66	-
Investing Cash Flow	-4.11	-6.42	-18.4	-4.81	79.96	-12.31
Short-Term Debt Issued	48.5	128.57	149.59	31.45	55.11	100
Short-Term Debt Repaid	-48.5	-145.76	-146.7	-54.64	-44.11	-148.4
Net Short-Term Debt Issued (Repaid)	-	-17.19	2.88	-23.19	11	-48.4
Long-Term Debt Issued	-	-	-	150	20	170
Long-Term Debt Repaid	-0.46	-0.93	-0.71	-123.69	-86.41	-114.13
Net Long-Term Debt Issued (Repaid)	-0.46	-0.93	-0.71	26.31	-66.41	55.87
Issuance of Common Stock	-0	23.85	0.72	4.82	-	-
Repurchase of Common Stock	-1.47	-1.27	-0.15	-0.27	-0.79	-0.41
Net Common Stock Issued (Repurchased)	-1.47	22.58	0.57	4.55	-0.79	-0.41
Issuance of Preferred Stock	-	-	-	38.08	-	-
Net Preferred Stock Issued (Repurchased)	-	-	-	38.08	-	-
Other Financing Activities	0.25	1.97	4.77	-6.05	-0.82	-10.48
Financing Cash Flow	5.07	6.42	7.51	39.7	-57.02	-3.42
Net Cash Flow	6.07	-0.2	-10.63	17.45	0.35	0.74
Free Cash Flow	-5.98	-13.62	-18.14	-38.92	-52.53	-8.75
FCF Margin	-4.69%	-10.57%	-14.14%	-37.69%	-47.21%	-8.68%
Free Cash Flow Per Share	-0.16	-0.39	-0.49	-1.30	-1.78	-0.30
Levered Free Cash Flow	-50.37	-70.3	3.3	-95.78	-181.66	-17.34
Unlevered Free Cash Flow	-16.14	-25.05	-19.89	-21.03	-23.6	-12.07

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q